Lupin Partners With Tenpoint to Bring YUVEZZI Eye Drops to European Markets
Indian pharmaceutical giant Lupin Limited has struck a licensing deal that will let its subsidiary VISUfarma B.V. sell YUVEZZI™, a presbyopia eye drop, across...
Charles River and Medigen Partner to Advance Next-Generation Enterovirus Vaccine
Charles River Laboratories International, Inc. (NYSE: CRL) has entered a collaboration with Taiwan-based Medigen Vaccine Biologics Corp. (MVC) to support development of MVC's next-generation multivalent enterovirus...
Ipsen Completes Kartos Therapeutics Acquisition to Boost Late-Stage Oncology Pipeline
Ipsen has officially completed its acquisition of KartosTherapeutics, a clinical-stage biopharmaceutical company. The transaction integrates navtemadlin, an investigational, first-in-class oral MDM2 inhibitor in Phase 3 clinical development,...
Union Minister Anupriya Patel announced India Must Move from ‘Pharmacy of the World’ to ‘Laboratory of the World
Addressing the third edition of the IIMA Healthcare Summit 2026 on the theme “Advancing AI in Healthcare,” Union Minister of State for Health &...
Sekhmet Pharmaventures Inaugurates Expanded Manufacturing Block at Unit 6 in Chennai
Sekhmet Pharmaventures has officially inaugurated its newly expanded manufacturing block at Unit 6, Chennai (Anjan Drug Private Limited). The expansion represents a key milestone in strengthening the...
First Autonomous Blood-Draw Robot Gets FDA Authorization
The U.S. Food and Drug Administration has given the green light to Aletta, a groundbreaking robotic system capable of performing blood draws entirely on its own...
